Bio X Cell InVivoSIM™
Biosimilar monoclonal antibodies
Bio X Cell InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic. Bio X Cell InVivoSIM™ antibodies feature greater than 95% purity and are free of preservatives, stabilizers, and carrier proteins. InVivoSIM™ antibodies are screened for murine pathogens and protein aggregation, feature binding validation via Immunoblot and are guaranteed to contain less than 1 endotoxin unit per milligram. InVivoSIM™ antibodies are for Research Use Only (RUO) and are not for therapeutic use.
|Art. Nr.||Product Name||Applications|
|BXC-SIM0008||InVivoSIM™ anti-human CD20 (Rituximab Biosimilar)||FC; ELISA; WB|
|BXC-SIM0004||InVivoSIM™ anti-human CTLA-4 (Ipilimumab Biosimilar)||CTLA-4 neutralization; FC; ELISA; WB|
|BXC-SIM0002||InVivoSIM™ anti-human EGFR (Cetuximab Biosimilar)||GFR blockade; ELISA; FC|
|BXC-SIM0005||InVivoSIM™ anti-human HER2 (Trastuzumab Biosimilar)||FC; ELISA; IHC; WB|
|BXC-SIM0003||InVivoSIM™ anti-human PD-1 (Nivolumab Biosimilar)||Blocking of PD-1/PD-L signaling; FC; IHC; WB|
|BXC-SIM0009||InVivoSIM™ anti-human PD-L1 (Atezolizumab Biosimilar)||FC; WB|
|BXC-SIM0001||InVivoSIM™ anti-human TNFα (Adalimumab Biosimilar)||TNFα neutralization; FC, ELISA; IF; IP; IHC; WB|
|BXC-SIM0006||InVivoSIM™ anti-human TNFα (Infliximab Biosimilar)||TNFα neutralization; FC; ELISA; WB|
|BXC-SIM0007||InVivoSIM™ anti-human VEGF (Bevacizumab Biosimilar)||VEGF neutralization; FC; ELISA; IP|
Take advantage of our new year offer with 30% discount on Bio X Cell antibodies!